RECRUITING

Towards Testing the Effectiveness of Recovery Community Centers (RCCs)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this pilot randomized clinical trial is to prepare for a larger randomized clinical trial (RCT) and collect some early data to learn if the intervention can help people who use medications for opioid use disorder (MOUD). The main questions it aims to answer are: 1. Is it feasible to recruit and randomize people to both treatment groups? 2. Does linking people to recovery community centers lead to better recovery outcomes? Researchers will compare linking people to recovery community centers (RCC) to enhanced treatment as usual to see if recovery outcomes are different. In one group, participants will learn about their local RCC and will be asked to visit their local RCC on at least two days and write about their experiences. In the other group, participants will learn about different recovery activities, pick any two, and do the activities of their choice on at least two days. They will also be asked to write about their experiences. People in both groups will answer online survey questions about their recovery outcomes and well-being in five surveys over one year.

Official Title

R34 Study 2 - Pilot RCT Testing the Effectiveness of RCCs

Quick Facts

Study Start:2025-08-20
Study Completion:2027-04-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07010978

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18+ years of age
  2. * Uses MOUD (at enrollment; participants may stop using MOUD subsequently) to treat OUD
  3. * Receives MOUD from a clinic/pharmacy located within 15 miles of an RCC vetted by our study team, which serves a Black community (i.e., defined as being located in a ZIP code where ≥27% of the residents are Black, as per US Census)
  4. * Is willing and able to engage in study procedures (i.e., online surveys, timeline follow back interview)
  5. * Is willing to be randomized
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Bettina Hoeppner, Ph.D., M.S.
CONTACT
617-643-1988
bhoeppner@mgh.harvard.edu
Susanne Hoeppner, PhD, MApStat
CONTACT
617-643-9934
shoeppner@mgh.harvard.edu

Principal Investigator

Bettina Hoeppner, Ph.D., M.S.
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Bettina Hoeppner, Ph.D., M.S., PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-20
Study Completion Date2027-04-15

Study Record Updates

Study Start Date2025-08-20
Study Completion Date2027-04-15

Terms related to this study

Keywords Provided by Researchers

  • opioid use disorder
  • moud
  • medications for opioid use disorder
  • recovery
  • recovery community centers

Additional Relevant MeSH Terms

  • Opioid Use Disorder